bullish
Caregen (214370 KS): Business Recovery Backed by Strong Global Demand; New Products Brighten Outlook
199 Views27 Sep 2022 21:52
SUMMARY
- Caregen Co Ltd (214370 KS) is a niche biotech company, with focus on biomimetic peptide-based cosmeceuticals and medical devices targeting anti-aging industry. The company has a large addressable market opportunity.
- Despite the negative impact from the re-spread of COVID-19, Caregen reported 4% y/y growth in total revenue in H1 2022, with operating profit margin expanding 260bps.
- Caregen’s COVID-19 nasal spray is in phase 1 trial. FDA has registered Caregen’s health functional food to control blood sugar as a new dietary ingredient (NDI).
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Caregen (214370 KS): ProGsterol May Rebound in 2024; Ophthalmic and COVID-19 Pipeline To Watch07 Jan 2024
- Caregen (214370 KS): Business Recovery Backed by Strong Global Demand; New Products Brighten Outlook27 Sep 2022
- KOSDAQ 150 Special Change: Momentum Trading on Caregen Right Before Inclusion22 Feb 2022
- The Blockchain Delusion. A (Mostly) Bearish Investment Thesis.25 Jun 2019
- Autonomous Driving- Are We There Yet?20 Mar 2018
x